顾筱莉, 成文武, 陈萌蕾. The characteristics of Traditional Chinese Medicine syndrome and its relationship with survival time among patients with advanced cancer[J]. China Oncology, 2018, 28(7): 532-537.
顾筱莉, 成文武, 陈萌蕾. The characteristics of Traditional Chinese Medicine syndrome and its relationship with survival time among patients with advanced cancer[J]. China Oncology, 2018, 28(7): 532-537. DOI: 10.19401/j.cnki.1007-3639.2018.07.010.
背景与目的:晚期癌症患者的中医辨证分型具有同西医症状评估不同的特点。通过对晚期癌症患者进行中医辨证分型的分类,研究其同西医症状及患者生存期之间的相关性。方法:通过MD Anderson症状评估量表(MD Anderson Symptom Inventory-Chinese,MDASI-C)收集临床患者症状分布及强度,并通过望闻问切判断患者的中医辨证分型。描述性分析用于人口统计学及临床特征资料的分析。对辨证分型为肝肾阴虚型(Ⅳ型)和其他型的患者进行t检验及χ
Background and purpose: Traditional Chinese Medicine (TCM) syndrome has different characteristics from symptom management of Western medicine. This study was focused on the characteristics of TCM syndrome in advanced cancer patients
and to study the correlation between TCM syndrome and Western medicine symptoms and their correlation with the survival time of patients. Methods: The symptom distribution and int
ensity of the patients were collected through MD Anderson Symptom Inventory-Chinese (MDASI-C). TCM syndrome was correlated by four ways of Chinese diagnosis (looking
listening
questioning and feeling the pulse). SPSS Statistical software package was used to analyze and process the data. Descriptive analysis was applied to the analysis of demographic and clinical characteristics. The t test and χ
2
test were performed for patients with syndrome differentiation type Ⅳ and other groups. The survival time was calculated using Kaplan-Meier method
and log-rank test was performed to measure the difference. Results: According to TCM syndrome differentiation
82 cases (36%) were diagnosed with liver and kidney Yin deficiency. Compared with the other 5 types
the frequency and intensity of fatigue and dyspnea were higher in patients with liver and kidney Yin deficiency. There was significant difference in survival time between type Ⅳ patients and other 5 type patients (P0.05). Eastern Cooperative Oncology Group (ECOG) score and type Ⅳ TCM syndrome were the survival prognostic factors in advanced cancer patients. Conclusion: Through this study
we have enhanced the identification of TCM syndrome differentiation in the survival of patients with advanced cancer
and improved the accuracy of predicting the survival of patients with advanced cancer. In clinical work
TCM syndrome can be used to assist in the detection of disease changes. It may help clinicians to assess survival prognosis.